Skip to content
contact@indiamedicine.orgLogin / Register
IMSDA
  • Home
  • About Us
  • Drugs
  • News
  • Knowledge
  • Members
  • Contact Us
Search for:
Menu Close
  • Home
  • About Us
  • Drugs
  • News
  • Knowledge
  • Members
  • Contact Us

cdsco

  1. Home>
  2. News>
  3. cdsco>
  4. Page 22

CDSCO 2026 Reforms: Prior Intimation, GMP Audits & Faster Drug Approvals

  • Post published:June 1, 2026
  • Post category:News

The Central Drugs Standard Control Organization (CDSCO), India's national drug regulatory authority, has undertaken the most significant regulatory modernization in its history during the first half of 2026. From introducing…

Continue Reading CDSCO 2026 Reforms: Prior Intimation, GMP Audits & Faster Drug Approvals

How to Verify the Quality of Indian Generic Medicines: A Buyer’s Guide

  • Post published:May 29, 2026
  • Post category:Knowledge

India is the largest supplier of generic medicines in the world, exporting over USD 50 billion worth of pharmaceuticals annually. Indian generics fill approximately 40% of the US generic drug…

Continue Reading How to Verify the Quality of Indian Generic Medicines: A Buyer’s Guide

How CDSCO Monitors Drug Quality in India: NSQ Alerts, Factory Inspections & Buyer Guide (2026)

  • Post published:May 27, 2026
  • Post category:Knowledge

🔬 How CDSCO Monitors Drug Quality in India: Understanding NSQ Alerts, Factory Inspections & What International Buyers Should Know India is one of the world's largest producers of generic medicines,…

Continue Reading How CDSCO Monitors Drug Quality in India: NSQ Alerts, Factory Inspections & Buyer Guide (2026)

CDSCO Launches Major Overhaul: Outsourcing GMP Audits and Building 1500-Expert Scientific Cadre

  • Post published:May 26, 2026
  • Post category:News

India's Central Drugs Standard Control Organisation (CDSCO) is embarking on the most significant regulatory restructuring in its history. In a move designed to strengthen pharmaceutical quality oversight and align with…

Continue Reading CDSCO Launches Major Overhaul: Outsourcing GMP Audits and Building 1500-Expert Scientific Cadre
  • Go to the previous page
  • 1
  • …
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • Go to the next page

Recent Posts

  • CDSCO Cancels FatX Import Registration Over Misleading Claims
    October 31, 2026/
    0 Comments
  • Understanding CDSCO’s NSQ Drug Quality Alerts: A Buyer’s Guide for 2026
    September 30, 2026/
    0 Comments
  • CDSCO’s Risk-Based Regulation Push at iPHEX 2026
    September 29, 2026/
    0 Comments

Follow Us

IMSDA

Recent Posts

  • CDSCO Cancels FatX Import Registration Over Misleading Claims
  • Understanding CDSCO’s NSQ Drug Quality Alerts: A Buyer’s Guide for 2026
  • CDSCO’s Risk-Based Regulation Push at iPHEX 2026
  • A Buyer’s Guide to WHO-GMP Certified Indian Generic Medicines
  • India’s PLI Bulk Drug Push: Rs 5,210 Crore Invested by June 2026

Contact Info

  • If you want to touch more medicine sales and distribution resources, you could contact us, or join us.
  • Address:2nd Floor, Bhavani CHS, Dadar West, Mumbai, 400028, Maharashtra.
  • Phone:+91 8048111688
  • Email:contact@indiamedicine.orgOpens in your application
  • Website:https://indiamedicine.org/
  • Home
  • About Us
  • Drugs
  • News
  • Knowledge
  • Members
  • Contact Us
© Copyright All Right Reserve